← Back to front page
Europe · Regional markets · Option Finance

Nanobiotix dévoile des résultats encourageants dans le traitement du mélanome avancé

Published by Option Finance · France 16 h ago

Nanobiotix a présenté de nouvelles données cliniques encourageantes concernant son candidat thérapeutique JNJ-1900 (NBTXR3) dans le traitement du mélanome cutané avancé résistant…

Read the full article on Option Finance Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (tribune-assurance.optionfinance.fr)

Also worth reading

This is Money

RUTH SUNDERLAND: Labour must tackle the cost-of-hiring catastrophe

 City A.M.

FTSE 100 Live: Stocks to rise; oil falls back as Trump weighs Iran deal

 Investors Chronicle

Will the Fed hike? Economic week ahead – 26-30 Oct

 Finews

Bitcoin Pioneer Adam Back Expands in Switzerland

 MoneyWeek

What is pension tax relief and how does it work?

 Maddyness

Et si c’était faux ?